Zymeworks Inc. (NYSE:ZYME) Q1 2024 Earnings Call Transcript

Zymeworks Inc. (NYSE:ZYME) Q1 2024 Earnings Call Transcript

Zymeworks Inc. (NYSE:ZYME) Q1 2024 Earnings Call Transcript May 2, 2024 Zymeworks Inc. misses on earnings expectations. Reported EPS is $-0.41513 EPS, expectations were $-0.31. Zymeworks Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. […]

Related Keywords

United States , Kansas , Ken Galbraith , Amgen , Tritce Co , Humanized Xenograft Model , Paul Moore , Zymeworks , Clinical Development , Development ,

© 2025 Vimarsana